BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 18295660)

  • 1. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.
    Park TS; Song J; Kim JS; Yang WI; Song S; Kim SJ; Suh B; Choi JR
    Cancer Genet Cytogenet; 2008 Mar; 181(2):93-9. PubMed ID: 18295660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [8p11 myeloproliferative syndrome with CEP110-FGFR1 fusion in a patient].
    Chao H; Chen S; Zhou M; Lu X; Zhang X; Pan J; Wu C; Zhang R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Oct; 32(5):679-82. PubMed ID: 26418991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of four new translocations involving FGFR1 in myeloid disorders.
    Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
    Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
    Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
    Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: An analysis of 16 cases show common features and poor prognosis.
    Chen M; Wang K; Cai X; Zhang X; Chao H; Chen S; Shen H; Wang Q; Zhang R
    Hematology; 2021 Dec; 26(1):153-159. PubMed ID: 33491601
    [No Abstract]   [Full Text] [Related]  

  • 7. A biphenotypic transformation of 8p11 myeloproliferative syndrome with CEP1/FGFR1 fusion gene.
    Yamamoto K; Kawano H; Nishikawa S; Yakushijin K; Okamura A; Matsui T
    Eur J Haematol; 2006 Oct; 77(4):349-54. PubMed ID: 16879608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literature.
    Mozziconacci MJ; Carbuccia N; Prebet T; Charbonnier A; Murati A; Vey N; Chaffanet M; Birnbaum D
    Leuk Res; 2008 Aug; 32(8):1304-8. PubMed ID: 18096225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular monitoring of 8p11 myeloproliferative syndrome in an infant.
    Zhang WW; Habeebu S; Sheehan AM; Naeem R; Hernandez VS; Dreyer ZE; López-Terrada D
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):879-83. PubMed ID: 19829149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular identification of a TPR-FGFR1 fusion transcript in an adult with myeloproliferative neoplasm, T-lymphoblastic lymphoma, and a t(1;8)(q25;p11.2).
    Kim SY; Kim JE; Park S; Kim HK
    Cancer Genet; 2014 Jun; 207(6):258-62. PubMed ID: 25037443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical pathological features of the 8p11 myeloproliferative syndrome].
    Yan Z; Yang B; Wang QS; Wang LL; Han XP; Ren F; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1321-6. PubMed ID: 21129285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
    Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome.
    Li F; Zhai YP; Tang YM; Wang LP; Wan PJ
    Genes Chromosomes Cancer; 2012 Sep; 51(9):890-7. PubMed ID: 22619110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.
    Xiao S; Nalabolu SR; Aster JC; Ma J; Abruzzo L; Jaffe ES; Stone R; Weissman SM; Hudson TJ; Fletcher JA
    Nat Genet; 1998 Jan; 18(1):84-7. PubMed ID: 9425908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution.
    Patnaik MM; Gangat N; Knudson RA; Keefe JG; Hanson CA; Pardanani A; Ketterling RP; Tefferi A
    Am J Hematol; 2010 Apr; 85(4):238-42. PubMed ID: 20143402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.
    Macdonald D; Reiter A; Cross NC
    Acta Haematol; 2002; 107(2):101-7. PubMed ID: 11919391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8p11 myeloproliferative syndrome with t(1;8)(q25;p11.2): a case report and review of the literature.
    Kim WS; Park SG; Park G; Jang SJ; Moon DS; Kang SH
    Acta Haematol; 2015; 133(1):101-5. PubMed ID: 25227135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.
    Kumar KR; Chen W; Koduru PR; Luu HS
    Am J Clin Pathol; 2015 May; 143(5):738-48. PubMed ID: 25873510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precursor T-Lymphoblastic Lymphoma Associated with t(8;9)(p11.2;q33): A Case Report and Review of the Literature.
    Lv H; Hu S; Lu J; Zhai Q; Zhai Z; Du Z; Sun Y; Li J; He H; Wang Y
    Acta Haematol; 2018; 139(3):176-182. PubMed ID: 29614500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloproliferative disorders with t(8;9)(p12;q33): a case report and review of the literature.
    Hu S; He Y; Zhu X; Li J; He H
    Pediatr Hematol Oncol; 2011 Mar; 28(2):140-6. PubMed ID: 21214407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.